Jane Street’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $753K | Buy |
|
|||||
|
2024
Q4 | $214K | Buy |
|
|||||
|
2024
Q3 | $46.9K | Sell |
|
|||||
|
2024
Q2 | $340K | Buy |
|
|||||
|
2024
Q1 | $36.4K | Buy |
|
|||||
|
2023
Q4 | $51.3K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $552K | Buy |
|
|||||
|
2023
Q1 | $83.3K | Sell |
|
|||||
|
2022
Q4 | $126K | Buy |
|
|||||
|
2022
Q3 | $82K | Sell |
|
|||||
|
2022
Q2 | $91K | Sell |
|
|||||
|
2022
Q1 | $154K | Buy |
|
|||||
|
2021
Q4 | $71K | Buy |
|
|||||
|
2021
Q3 | $54K | Buy |
|
|||||
|
2021
Q2 | $60K | Sell |
|
|||||
|
2021
Q1 | $215K | Buy |
|
|||||
|
2020
Q4 | $81K | Buy |
|
|||||
|
2020
Q3 | $57K | Sell |
|
|||||
|
2020
Q2 | $542K | Buy |
|
|||||
|
2020
Q1 | $124K | Buy |
|
|||||
|
2019
Q4 | $105K | Buy |
|
|||||
|
2019
Q3 | $3K | Sell |
|
|||||
|
2019
Q2 | $14K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $24K | Buy |
|
|||||
|
2018
Q3 | $41K | Buy |
|
|||||
|
2018
Q2 | $19K | Buy |
|
|||||
|
2018
Q1 | $20K | Sell |
|
|||||
|
2017
Q4 | $25K | Sell |
|
|||||
|
2017
Q3 | $26K | Sell |
|
|||||
|
2017
Q2 | $57K | Sell |
|
|||||
|
2017
Q1 | $255K | Sell |
|
|||||
|
2016
Q4 | $173K | Buy |
|
|||||
|
2016
Q3 | $8K | Buy |
|
|||||
|
2016
Q2 | $9K | Sell |
|
|||||
|
2016
Q1 | $33K | Sell |
|
|||||
|
2015
Q4 | $144K | Buy |
|
|||||
|
2015
Q3 | $49K | Sell |
|
|||||
|
2015
Q2 | $237K | Buy |
|
|||||
|
2015
Q1 | $27K | Sell |
|
|||||
|
2014
Q4 | $91K | Buy |
|
|||||
|
2014
Q3 | $82K | Buy |
|
|||||
|
2014
Q2 | $53K | Buy |
|
|||||
|
2014
Q1 | $49K | Buy |
|
|||||
|
2013
Q4 | $42K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $64K | Buy |
|